Search bioRxiv⌕ Search

Biology subjects

Caldecott, K. W.

Publications and source records attributed to Caldecott, K. W..

3 recordsLinked to original sources

DNA Polymerase beta Accelerates Cellular DNA Base Excision Repair by Suppressing Excessive PARP1 Engagement

DNA polymerase beta (POL{beta}) is required for rapid rates of cellular DNA base excision repair (BER). However, the reason for this requirement is unclear, because other DNA polymerases can replace POL{beta}, in vitro. Here, we have identified the essential role of POL{beta} during cellular BER. As expected, POL{beta} deletion in human RPE-1 cells resulted in the rapid accumulation of DNA strand break intermediates during incubation with the monofunctional alkylating agent, methyl methanesulphonate (MMS). However, this accumulation was not detected in cells that also lack PARP1, indicating that POL{beta} is required for BER only if PARP1 is present. This result is reminiscent of the essential role of XRCC1 during BER, which is to suppress the excessive engagement and activity of PARP1 at BER intermediates and thereby enable their access and repair by other enzymes. Indeed, we found that POL{beta} is required to prevent excessive PARP1 engagement and activity during BER, and that XRCC1 and POL{beta} fulfil this function together. Finally, similar to XRCC1, loss of POL{beta} leads to persistent transcriptional suppression during MMS-induced BER, and this suppression is alleviated by treatment with PARP inhibitor. In summary, we show here that the essential role of POL{beta} during cellular BER is to suppress excessive PARP1 engagement and activity, and thereby maintain rapid rates of this important DNA repair process.

molecular biology↗

Parp1 deletion rescues cerebellar hypotrophy in xrcc1 mutant zebrafish

Defects in DNA single-strand break repair are associated with neurodevelopmental and neurodegenerative disorders. One such disorder is that resulting from mutations in XRCC1, a scaffold protein that plays a central role in DNA single-strand base repair. XRCC1 is recruited at sites of single-strand breaks by PARP1, a protein that detects and is activated by such breaks and is negatively regulated by XRCC1 to prevent excessive PARP binding and activity. Loss of XRCC1 leads to the toxic accumulation and activity of PARP1 at single-strand breaks leading to base excision repair defects, a mechanism that may underlie pathological changes in patients carrying deleterious XRCC1 mutations. Here, we demonstrate that xrcc1 knockdown impairs development of the cerebellar plate in zebrafish. In contrast, parp1 knockdown alone does not significantly affect neural development, and instead rescues the cerebellar defects observed in xrcc1 mutant larvae. These findings support the notion that PARP1 inhibition may be a viable therapeutic candidate in neurological disorders.

neuroscience↗

The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signalling

SARS-CoV-2 non-structural protein 3 (Nsp3) contains a macrodomain that is essential for virus replication and is thus an attractive target for drug development. This macrodomain is thought to counteract the host interferon (IFN) response, an important antiviral signalling cascade, via the removal of ADP-ribose modifications catalysed by host poly(ADP-ribose) polymerases (PARPs). Here, we show that activation of the IFN response induces ADP-ribosylation of host proteins and that ectopic expression of the SARS-CoV-2 Nsp3 macrodomain reverses this modification in human cells. We further demonstrate that this can be used to screen for cell-active macrodomain inhibitors without the requirement for BSL-3 facilities. This IFN-induced ADP-ribosylation is dependent on the PARP9/DTX3L heterodimer, but surprisingly the expression of Nsp3 macrodomain or PARP9/DTX3L deletion do not impair STAT1 phosphorylation or the induction of IFN-responsive genes. Our results suggest that PARP9/DTX3L-dependent ADP-ribosylation is a downstream effector of the host IFN response and that the cellular function of the SARS-CoV-2 Nsp3 macrodomain is to hydrolyse this end product of IFN signalling, and not to suppress the IFN response itself.

molecular biology↗